Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.5700 (-4.5%) ($13.3700 - $14.2400) on Mon. Dec. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.1% (three month average) | RSI | 61 | Latest Price | $13.5700(-4.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.05% in a week (0% probabilities). VIXM(-36%) VXX(-35%) TLT(-11%) UNG(-7%) UUP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.05% (StdDev 4.1%) | Hourly BBV | 0 () | Intraday Trend | -3.7% | | | |
|
5 Day Moving Average | $13.94(-2.65%) | 10 Day Moving Average | $13.95(-2.72%) | 20 Day Moving Average | $13.49(0.59%) | To recent high | -16.4% | To recent low | 24.6% | Market Cap | $1.008b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |